Serious adverse events of special interest following mRNA vaccination in randomized trials
Fraimen et al, testified at FDA meetings, SAEs did not look good coming out of clinical trials and portended safety concerns that fully developed in the post-release EUA era. Now complete safety debacle with World Council for Health, 6/11, calling for complete market withdrawal.
Serious-adverse-events-of-special-interestSource: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4125239